Rationale: The recent emergence of hydrogen sulfide (H 2 S) as a potent cardioprotective signaling molecule necessitates the elucidation of its cytoprotective mechanisms. Objective: The present study evaluated potential mechanisms of H 2 S-mediated cardioprotection using an in vivo model of pharmacological preconditioning. Methods and Results: H 2 S (100 g/kg) or vehicle was administered to mice via an intravenous injection 24 hours before myocardial ischemia. Treated and untreated mice were then subjected to 45 minutes of myocardial ischemia followed by reperfusion for up to 24 hours, during which time the extent of myocardial infarction was evaluated, circulating troponin I levels were measured, and the degree of oxidative stress was evaluated. In separate studies, myocardial tissue was collected from treated and untreated mice during the early (30 minutes and 2 hours) and late (24 hours) preconditioning periods to evaluate potential cellular targets of H 2 S. Initial studies revealed that H 2 S provided profound protection against ischemic injury as evidenced by significant decreases in infarct size, circulating troponin I levels, and oxidative stress. During the early preconditioning period, H 2 S increased the nuclear localization of Nrf2, a transcription factor that regulates the gene expression of a number of antioxidants and increased the phosphorylation of protein kinase C and STAT-3. During the late preconditioning period, H 2 S increased the expression of antioxidants (heme oxygenase-1 and thioredoxin 1), increased the expression of heat shock protein 90, heat shock protein 70, Bcl-2, Bcl-xL, and cyclooxygenase-2 and also inactivated the proapoptogen Bad. Conclusions: These results reveal that the cardioprotective effects of H 2 S are mediated in large part by a combination of antioxidant and antiapoptotic signaling. (Circ Res. 2009;105:365-374.) 
H ydrogen sulfide (H 2 S) is an endogenously produced gaseous signaling molecule with a diverse physiological profile. Its production in mammalian systems has been attributed to 2 key enzymes in the cysteine biosynthesis pathway, cystathionine ␤-synthase (CBS) and cystathionine ␥-lyase (CGL). The rate of H 2 S production in tissue homogenates is in the range of 1 to 10 pmol per second per milligram of protein, resulting in low micromolar extracellular concentrations. 1, 2 It is at these physiological concentrations that H 2 S is cytoprotective in various models of cellular injury. 3, 4 The reported cytoprotective effects of H 2 S are partially related to its ability to neutralize reactive oxygen species (ROS), to inhibit leukocyte-endothelial cell interactions, to promote vascular smooth muscle relaxation, to reduce apoptotic signaling, and to reversibly modulate mitochondrial respiration. 5 Pretreatment with NaHS has been reported to reduce the number and duration of arrhythmias in isolated hearts subjected to global ischemia/reperfusion (I/R) 6 and to enhanced the viability of isolated rat ventricular myocytes exposed to glucose deprivation and 2-deoxyglucose. 4 Recently, Elrod et al 7 reported that the administration of H 2 S at the time of reperfusion decreased infarct (INF) size and preserved left ventricular (LV) function in an in vivo model of myocardial I/R. Additional findings from this study also demonstrated that cardiac-specific overexpression of CGL likewise limited the extent of myocardial I/R injury. The findings of these studies and others suggest that H 2 S is cytoprotective during myocardial I/R injury and that either direct H 2 S administration or the modulation of endogenous H 2 S production may be of clinical importance.
Although the physiological and cardioprotective effects of H 2 S have previously been documented, the signaling mech-anisms that mediate these effects have not been fully evaluated. Moreover, the signaling mechanisms that have been attributed to the cardioprotective effects of H 2 S have predominantly been studied in in vitro model systems, with very few studies actually exploring the protective effects in in vivo systems. Therefore, the purpose of the present study was to evaluate signaling mechanisms triggered by H 2 S treatment using an in vivo model of pharmacological preconditioning (PC). This model was chosen as a model for which early and delayed cellular targets responsible for H 2 S-mediated cardioprotection could be identified. Additionally, a cardiacspecific transgenic mouse that overexpresses CGL was used to evaluate signaling mechanisms mediated by endogenous H 2 S.
Methods
An expanded Methods section is available in the Online Data Supplement at http://circres.ahajournals.org.
Animals
Male C57BL6/J mice, 8 to 10 weeks of age, were used (The Jackson Laboratory, Bar Harbor, Me). The generation of cardiac-specific transgenic mice overexpressing CGL (␣MHC-CGL-Tg; FVB background), 7 as well as the generation of Nrf2-deficient mice (Nrf2 knockout [KO]; ICR background), 8 
Materials
H 2 S was administered in the form of sodium sulfide (Na 2 S). Na 2 S was produced by Ikaria Holdings Inc (Seattle, Wash) using H 2 S gas (Matheson, Newark, Calif) as a starting material and was formulated to pH neutrality, and isoosmolarity. Na 2 S (stock solution at 0.55 mg/mL and 7.1 mmol/L) was diluted in normal (0.9%) saline to the desired concentration in a rapid fashion, immediately before administration. For all experiments, normal saline (100 L) or Na 2 S (100 g/kg) in a final volume of 100 L was injected intravenously into the femoral vein using a 32-gauge needle. For this study, H 2 S denotes Na 2 S.
Myocardial I/R Protocol and Myocardial Injury Assessment
Surgical ligation of the left coronary artery (LCA), myocardial INF size determination, troponin I measurements, and LV echocardiography were performed similarly to methods described previously. 9
Glutathione and Lipid Hydroperoxide Assays
Cardiac glutathione and lipid hydroperoxides were measured in heart tissue collected from mice subjected to 45 minutes of myocardial ischemia and 1, 4, or 24 hours of reperfusion using commercially available kits (Cayman Chemicals) as previously described. 3 Glutathione (GSH) and GSH disulfide (GSSG) values were used to calculate the steady-state redox potential using the Nernst equation, as described previously. 10
Tissue Collection for Western Blot Analysis
For the evaluation of cellular targets during early and late phase preconditioning, mice were administered H 2 S as described above and then euthanized 30 minutes, 2 hours, and 24 hours after the injection. The hearts were rapidly excised and the LV was isolated and snap frozen in liquid nitrogen. The samples were then stored at Ϫ80°C. In a separate group of mice, heart samples were obtained following 45 minutes of myocardial ischemia and 4 hours of reperfusion.
Western Blot Analysis
Whole cell, cytosolic, membranous, nuclear, and mitochondrial fractions were prepared as described previously. 11 Equal amounts of protein were loaded into lanes of polyacrylamide-sodium dodecyl sulfate gels and Western blot analysis was performed as previously described. 9
TUNEL Staining
Following 45 minutes of ischemia and 4 hours of reperfusion hearts from sham-, vehicle (Veh)-, and H 2 S PC-treated mice were rapidly excised, cross-sectioned into 3 sections, and fixed in 10% buffered formalin. Fixed tissue was then paraffin-embedded and sectioned in a standard fashion. TUNEL staining was conducted using a kit according to the instructions of the manufacturer (ApopTag HRP kit, DBA). The number of TUNEL-positive nuclei and the total number of nuclei per high-powered field were counted in a minimum of 10 fields from the area at risk (AAR) portion of the myocardium for each section (a total of 30 fields per heart).
Statistical Analysis
All data in this study are expressed as meansϮSEM. Differences in data between the groups were compared using Prism 4 (GraphPad Software Inc), with Student's paired 2-tailed t test, 1-way ANOVA with post hoc Tukey test, or 2-way ANOVA with post hoc Bonferroni analysis where appropriate. A probability value of Ͻ0.05 was considered significant.
Results

H 2 S PC Limited the Extent of Myocardial Injury Following I/R
Initial experiments were conducted to investigate if H 2 S PC could limit myocardial I/R injury, For these experiments, mice were subjected to 45 minutes of LCA ischemia followed by 24 hours of reperfusion. H 2 S (Na 2 S; 100 g/kg) or Veh was administered 24 hours before ischemia via an intravenous injection. The extent of myocardial infarction was then evaluated at 24 hours of reperfusion. Representative photomicrographs of midventricular cross sections of 2,3,5-triphenyltetrazolium chloride-stained hearts taken from Veh-and H 2 S PC-treated mice are shown in Figure 1A . The AAR per LV was similar (PϭNS) in all of the groups ( Figure 1B ). H 2 S PC decreased the INF relative to the AAR (INF/AAR) by 46% (48Ϯ3 versus 26Ϯ3%, PϽ0.001) and the INF relative to the entire LV (INF/LV) by 48% (29Ϯ2.5 versus 15Ϯ2%, PϽ0.001) when compared to Veh-treated mice. Circulating levels of troponin I were evaluated as an additional marker of myocardial injury at 24 hours of reperfusion ( Figure 1C ). Following myocardial I/R, circulating levels of troponin I rose from undetectable levels in sham-operated mice to 75Ϯ9 ng/mL in the Veh-treated group (PϽ0.001 versus sham). H 2 S PC significantly (Pϭ0.026) attenuated the rise in circulating troponin I by 69% (75Ϯ9 versus 23Ϯ7 ng/mL), thus confirming the cardioprotective effects of H 2 S PC. The effects of H 2 S PC on LV structure and function following myocardial I/R were evaluated in separate groups of mice using in vivo transthoracic echocardiography. For these experiments, mice were subjected to 45 minutes of myocardial ischemia and 7 days of reperfusion. Myocardial I/R increased LV end-diastolic diameter (PϭNS) and LV end-systolic diameter (LVESD, PϽ0.05) in both groups compared to their respective baseline readings (Online Figure  I) . However, the increase in LV end-diastolic diameter (Pϭ0.12 versus I/RϩVeh) and LVESD (Pϭ0.03 versus I/RϩVeh) was attenuated in mice pretreated with H 2 S. Following myocardial I/R, LV ejection fraction ( Figure 1D ) decreased in both groups (PϽ0.001 versus baseline). H 2 S PC did, however, significantly improve ejection fraction by 87% (Pϭ0.006 versus I/RϩVeh). Together, these results suggest that H 2 S PC limits the extent of damage to the myocardium following I/R injury.
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H 2 S PC Reduced Oxidative Stress and Apoptosis Following I/R
There is considerable evidence that implicates the production of ROS as an initial cause of injury to the myocardium following I/R. 12 To evaluate the effects of H 2 S PC on cellular oxidative stress, lipid hydroperoxide levels were measured in tissue isolated from the hearts of Veh and H 2 S PC treated mice. In response to myocardial I/R injury, the redox potential (E h ) ( Figure 2A ) significantly increased in the hearts of Veh-treated mice. This change in redox potential was accom- panied by a significant rise in lipid hydroperoxide levels ( Figure 2B , PϽ0.001 versus sham). In contrast, the redox potential was preserved in the H 2 S PC treated hearts (PϽ0.05 versus I/RϩVeh) and a significant less rise in lipid hydroperoxide levels was also evident (PϽ0.05 versus I/RϩVeh). To investigate the effects of H 2 S PC on apoptosis, the expression of uncleaved caspase-3, cleaved caspase-3 and cytochrome c, as well as the extent of TUNEL-positive staining, was evaluated after 45 minutes of LCA and 4 hours of reperfusion in heart samples from sham-, Veh-, and H 2 S PC-treated mice ( Figure 2C through 2F). Myocardial I/R induced a significant decrease in the expression of uncleaved caspase-3 and in-duced a significant increase in the expression of cleaved caspase-3, as well as induced the translocation of cytochrome c from the mitochondria to the cytosol in the hearts of Veh-treated mice (PϽ0.01 versus sham). This was accompanied by a significant increase in the number of TUNELpositive nuclei (PϽ0.001 versus sham). In contrast, the hearts of H 2 S PC-treated mice when compared to Veh-treated hearts exhibited a significant preservation of uncleaved caspase-3, a significant reduction in cleaved caspase-3 (PϽ0.01 versus I/RϩVeh), a significant reduction in the translocation of cytochrome c (PϽ0.05 versus I/RϩVeh), and fewer TUNELpositive nuclei (PϽ0.001 versus I/RϩVeh). 
H 2 S Increased the Nuclear Accumulation of Nrf2 and Increased the Protein Expression of Thioredoxin and Heme Oxygenase-1
Nuclear factor E2-related factor (Nrf2) is a key transcription factor that regulates antioxidant genes as an adaptive response to oxidative stress or pharmacological stimuli. To investigate whether H 2 S induced Nrf2 signaling, H 2 S was administered to mice via an intravenous injection and heart tissue was excised at different times following this administration. As early as 30 minutes following the administration of H 2 S, Nrf2 accumulated in the nucleus of cardiac tissue and remained at an elevated level for at least 2 hours ( Figure 3A and 3B) . Subsequently, the protein expression ( Figure 3C and 3D) of 2 downstream targets of Nrf2, thioredoxin (Trx)1 and heme oxygenase (HO)-1, were elevated 24 hours following the administration H 2 S. H 2 S did not increase the protein expression of either copper zinc superoxide dismutase or manganese superoxide dismutase ( Figure 3C and 3D) at this latter time point.
To determine whether H 2 S upregulated HO-1 and Trx1 in an Nrf2-dependent manner, subsequent experiments were performed with mice deficient in Nrf2 (Nrf2 KO). For these experiments, H 2 S was administered as noted above and heart tissue was excised 24 hours later ( Figure 4A and 4B ). H 2 S slightly increased the expression of Trx1 (PϽ0.05 versus sham) but failed to increase the expression of HO-1 in the hearts of Nrf2 KO mice. Subsequent experiments were then conducted to determine whether Nrf2 was critical for the cardioprotective actions of H 2 S PC. For these experiments, H 2 S (Na 2 S; 100 g/kg) or Veh was administered 24 hours before ischemia via an intravenous injection to Nrf2 KO mice and wild-type littermates. H 2 S PC reduced INF/AAR and reduced circulating troponin I levels when it was administered to wild-type mice. Myocardial injury following I/R was found to be exacerbated in Nrf2 KO mice compared with wild-type mice ( Figure 4C and 4D) , as evidenced by an increase in INF/AAR (44Ϯ5 versus 25Ϯ2, PϽ0.01) and circulating troponin I levels (52.4Ϯ9.0 versus 26Ϯ5.2, PϽ0.01). H 2 S failed to provide protection in the Nrf2 KO mice, suggesting that Nrf2 plays a role in the cardioprotection actions mediated by H 2 S. The smaller INF size reported here for the wild-type mice in these experiments as compared to the size reported in Figure 1 is indicative of the background strain of these mice (ICR), because past studies have reported the different susceptibility of various strains of mice to myocardial injury. 9, 13 
H 2 S Activated a Protein Kinase C-p44/42-STAT-3 Prosurvival Signaling Pathway
H 2 S has been reported to induce protein kinase (PK)C activation in isolated rat cardiomyocytes. 14 To investigate whether H 2 S induced PKC activation in vivo, the translocation of PKC from the cytosolic fraction to the membranous fraction was evaluated after a single administration of H 2 S. A marked increase in the phosphorylated form of PKC at serine residue 729 (PKC-P Ser729 ) was evident in the membranous fraction (PϽ0.05 versus sham, Figure 5A ) 30 minutes and 2 hours following the administration of H 2 S. The total membrane levels of PKC were also increased during this time period (PϽ0.05 versus sham,), indicating translocation of PKC to the membrane. In addition, H 2 S increased the phosphorylation of p44/42, a downstream effector of PKC (PϽ0.05 versus sham, Figure 5B ). H 2 S did not change the total levels of PKC or alter the phosphorylation state PKC in the cytosolic fraction and did not change the total levels of p44/42.
The activation of prosurvival kinases, such as PKC and p44/42, has been demonstrated to confer cardioprotection through an upregulation of antiapoptotic signaling mediated in part by signal transducers and activators of transcription-3 (STAT-3). 15 In the present study, H 2 S increased the translocation of STAT-3 to the nucleus ( Figure 5C ), as evidenced by a decrease in the total cytosolic levels of STAT-3 (PϽ0.01 versus sham) and an increase in the total nuclear levels of STAT-3 (PϽ0.05 versus sham) from 30 minutes to 2 hours after its administration. A marked increase in the phosphorylated form of STAT-3 (PϽ0.01 and PϽ0.05 versus sham) at serine residue 727 (STAT-3P Ser727 ) was also evident in both the cytosolic fraction and nuclear fraction of H 2 S-treated hearts during this time period. H 2 S also increased the phosphorylation of Bad ( Figure 6A and 6B) at serine residue 112 (Bad-P Ser112 ) in both the mitochondrial (PϭNS) and the cytosolic fraction (PϽ0.05 versus sham) 24 hours after its administration. As a result of this phosphorylation, H 2 S induced the translocation of Bad from the mitochondria to the cytosol, as evidenced by a significant increase in the total cytosolic levels of Bad (PϽ0.05 versus sham). Further analysis revealed that H 2 S increased the protein expression of heat shock protein (HSP)90, HSP70, Bcl-2, Bcl-xL, and cyclooxygenase-2 ( Figure 6C and 6D, PϽ0.05 and PϽ0 .01 versus sham) 24 hours after its administration. These data suggest that in addition to promoting antioxidants, H 2 S also increased antiapoptogens.
The Overexpression of CGL Increased Nrf2 Nuclear Accumulation and Activated PKC, p44/42, and STAT-3
Previously, the cardiac-specific overexpression of CGL was shown to increase H 2 S production in the heart and reduce the degree of injury following myocardial I/R. 7 Therefore, the next series of experiments were conducted to evaluate if endogenous H 2 S activated the same cardioprotective signaling pathways as exogenous H 2 S. The overexpression of CGL resulted in the accumulation of Nrf2 in the nucleus of hearts isolated from transgenic mice (PϽ0.01 versus nontransgenic [Non-Tg], Figure 7A) . Although there was a trend for a decline, cytosolic Nrf2 levels were not significantly different between the groups of mice. A marked increase in PKC-P Ser729 was evident in both the cytosolic (PϽ0.05 versus Non-Tg, Figure 7B ) and membranous fractions (PϽ0.01 versus Non-Tg) of hearts isolated from CGL-Tg ϩ mice. The total membrane levels of PKC were also increased in the hearts of CGL-Tg ϩ mice (PϽ0.05 versus Non-Tg), indicating translocation of PKC to the membrane. CGL overexpression also induced the translocation of STAT-3 to the nucleus, as evidenced by an increase in the total nuclear levels of STAT-3 (PϽ0.01 versus Non-Tg, Figure 7C ). A marked increase in STAT-3P Ser727 was also evident in the cytosolic (PϽ0.01 versus Non-Tg) and nuclear fractions (PϽ0.05 versus Non-Tg) of CGL-Tg ϩ hearts. Further analysis revealed that hearts from CGL-Tg ϩ mice have increased protein expressions of HSP90, HO-1, Trx-1, and Bcl-2 (PϽ0.05 and PϽ0.01 versus Non-Tg, Figure 7D ).
Discussion
As a gaseous signaling molecule, H 2 S is able to freely diffuse across cell membranes in a receptor-independent manner and activate various cellular targets. This distinct ability makes H 2 S an attractive pharmacological agent for the treatment of cardiovascular disease. The present study highlights 2 signaling cascades which lead to the upregulation of antioxidants and antiapoptogens and provides evidence that pharmacological preconditioning with H 2 S results in profound protection against myocardial I/R injury, as evidenced by a significant Under physiological conditions, small amounts of ROS produced in cells are quenched by cellular antioxidant defense systems. Antioxidants act by scavenging oxidative species and their precursors, inhibiting their formation, and enhancing endogenous antioxidant defenses. 16 There is considerable evidence that implicates the production of ROS and subsequent related cellular damage as an initial cause of injury to the myocardium following I/R injury. 12 Therefore, the capacity of cardiac myocytes to maintain homeostasis during periods of oxidative stress resides in the ability to activate or induce protective enzymes. 17 However, during I/R the activity of many of the endogenous antioxidant enzyme systems are compromised or even abolished, 18 suggesting that increasing the activity of cellular antioxidant enzymes may protect tissues against reperfusion damage. 19 Previous studies have reported that H 2 S protects various cell types, including myocytes, 20 from oxidative stress. There is some debate, however, regarding the nature in which H 2 S reduces oxidative stress. H 2 S acts as a direct scavenger of ROS and upregulates endogenous antioxidant defenses. Kimura and Kimura 21 demonstrated that H 2 S protects neurons from cell death by increasing GSH levels through an enhancement of ␥-glutamylcysteine synthetase activity and an upregulation of cystine transport. A major finding of the present study supports the latter notion of H 2 S inducing a signaling mechanism to combat oxidative stress, as evidenced by the ability of H 2 S to upregulate cellular antioxidants in the heart in a Nrf2-dependent manner. Nrf2, a member of the NF-E2 family of nuclear basic leucine zipper transcription factors, regulates the gene expression of a number of enzymes that serve to detoxify prooxidative stressors. 22 This regulation is mediated by Nrf2 binding to the antioxidant responsive element, a cis-acting regulatory element or enhancer sequence found in the promoter region of certain genes, including HO-1 and Trx1. In the present study, H 2 S was shown for the first time to induce the nuclear accumulation of Nrf2 very rapidly after its administration and to subsequently increase the protein expression of HO-1 and Trx1. Additionally, this is the first study to report that Nrf2 deficient mice experienced an exacerbated injury in response to myocardial I/R, suggesting that Nrf2 is an important endogenous cardioprotective signal that protects against oxidant-mediated injury. This is further supported by previous reports indicating that Nrf2 deficiency is associated with enhanced oxidative stress and cell death. 23, 24 In the present study, H 2 S modestly increased the expression of Trx1, but failed to increase the expression of HO-1 in the hearts of Nrf2 KO mice. This is an important finding because the increase in Trx1 was found to be only 58% of the increase observed in wild-type mice (1.4Ϯ0.1 versus 3.3Ϯ0.7), suggesting that H 2 S upregulates HO-1 in an Nrf2dependent manner but only partially upregulates Trx1 in an Nrf2-dependent manner. This indicates that H 2 S regulates Trx1 expression through an additional unidentified mechanism. Interestingly, the modest increase in Trx1 levels in the Nrf2 KO hearts was not sufficient to induce protection, because H 2 S failed to reduce myocardial injury following I/R in these mice. Our data indicate that Nrf2 plays an important role in mediating the cardioprotective effects of H 2 S and provides important evidence linking Nrf2 and its downstream effectors to the antioxidant effects of H 2 S. Moreover, these results suggest that H 2 S therapy enhances the endogenous antioxidant defenses of myocytes and create an environment resistant to the oxidative stress associated with myocardial I/R injury, as evidenced by the preservation of redox state and a reduction in lipid peroxidation.
Another major finding of the present study relates to H 2 S-medaited activation of a PKC-STAT-3 signaling cascade. Although, there is in vitro evidence in the literature suggesting that H 2 S activates PKC, 14 the present study is the first to report that H 2 S activates PKC in vivo. The activation of this prosurvival signaling cascade has previously been shown to confer cardioprotection against myocardial I/R through inhibition of apoptotic cell death 25 and activation of cyclooxygenase-2 and has been shown to play a prominent role in the cardioprotective signaling of ischemic PC. 26 The antiapoptotic actions of this pathway are mediated in part by the phosphorylation and inhibition of the proapoptotic factor Bad, 27 upregulation of the prosurvival factors Bcl-2 and Bcl-xL, 28 and upregulation of HSPs. 29 p44/42 promotes the phosphorylation of Bad through the actions of p90RSK, whereas it upregulates Bcl-2, Bcl-xL, and HSPs through STAT-3. The STAT pathway has recently been shown to be an integral part of the response of the myocardium to various cardiac insults, including myocardial infarction. 30 In particular, the overexpression of STAT-3 results in cardioprotection, 31 whereas cardiac-specific deficiency of STAT-3 exacerbates cardiac injury. 32 HSPs have also been demonstrated to provide cardioprotection in the setting of I/R. 33 In particular, HSP70 suppresses apoptosis in a caspase-dependent 34 and caspase-independent manner. 35 The findings of the present study suggest that H 2 S therapy does not simply reduce apoptotic cell death following myocardial I/R through a reduction in oxidative stress, but actually promotes direct antiapoptotic signaling.
The activation of multiple pathways by H 2 S in the present study highlights the diversity of this gasotransmitter. Unlike other pharmacological agents that rely on receptor-mediated signaling, H 2 S activates multiple pathways simultaneously. In addition to the pathways studied here, H 2 S could promote cardioprotection via the activation of K ATP channels and by inhibiting leukocyte-endothelial interactions and subsequent inflammation. 2 An important question that remains unanswered relates to the mechanism by which H 2 S induces the nuclear accumulation of Nrf2. Under basal conditions, Keap1 (Kelch ECH associating protein 1) represses the ability of Nrf2 to induce endogenous antioxidants by binding very tightly to Nrf2, anchoring it in the cytoplasm, and targeting it for ubiquitination and proteasome degradation. 36 Only when this association is disrupted can Nrf2 translocate to the nucleus and bind antioxidant responsive elements. It is thought that several critical cysteine residues in Keap1 serve as the primary sensor for stress signals (ie, ROS) and that their modification leads to conformational changes in Keap1, which results in the release of Nrf2. 36 In addition to Keap1 being a target, Nrf2 can also be directly modified by kinases, such as PKC, to induce its release. 37 Whether H 2 S alters Keap1 and/or Nrf2 directly or through upstream signaling (ie, PKC) remains an important unanswered question that requires further study.
Together, the findings of the present study indicate that the cardioprotective effects of H 2 S are mediated in large part by a combination of antioxidant and antiapoptotic signaling and highlight a novel signaling cascade involving Nrf2. Furthermore, this study suggests that either the administration of H 2 S donors or the modulation of the endogenous production of H 2 S may be of therapeutic benefit in the setting of myocardial I/R.
